---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-102419"
form_type: "8-K"
ticker: "LITS"
cik: "0001262104"
company_name: "Lite Strategy, Inc."
filed_at: "2025-08-05T23:59:59+00:00"
generated_at: "2026-05-17T20:29:11.113758+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# MEI Pharma acquires ~$110M in Litecoin, becomes first US-listed company to adopt LTC as primary reserve

## Summary
- Acquired 929,548 LTC tokens at avg price $107.58; LTC treasury valued at ~$110.4M as of Aug 4, 2025.
- Deployed all net proceeds from July 17, 2025 PIPE Offering with Titan Partners as placement agent.
- Strategy developed with GSR; Litecoin creator Charlie Lee (MEI board member) providing guidance.
- Company plans to update corporate identity and may start Litecoin mining; continues pre-clinical drug pipeline voruciclib.
- First US-listed public company to adopt Litecoin as primary reserve asset for treasury strategy.

## SEC filing metadata
- accession: 0000950170-25-102419
- form_type: 8-K
- ticker: LITS
- cik: 0001262104
- company_name: Lite Strategy, Inc.
- filed_at: 2025-08-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1262104/000095017025102419/0000950170-25-102419-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1262104/000095017025102419/meip-20250805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-102419
- JSON: https://secwatch.observer/filing/0000950170-25-102419.json
- Plain text: https://secwatch.observer/filing/0000950170-25-102419.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.